Shiro Takamatsu
11PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinoma.Shunsuke Kawahara, Mana Taki, Junzo Hamanishi
|Dec 09, 2024
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors.Thomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus
|Aug 30, 2024
Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study.Shiro Takamatsu, R Tyler Hillman, Kosuke Yoshihara
|Jul 03, 2024
YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma.Yoko Furutake, Ken Yamaguchi, Koji Yamanoi
|Feb 06, 2024
Homologous Recombination Deficiency Unrelated to Platinum and PARP Inhibitor Response in Cell Line Libraries.Shiro Takamatsu, Kosuke Murakami, Noriomi Matsumura
|Jan 02, 2023
Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study.Shiro Takamatsu, Kosuke Yoshihara, Tsukasa Baba
Pageof 2
Frequent Collaborators
9 joint publications
Noriomi Matsumura
6 joint publications
Junzo Hamanishi
5 joint publications
Ken Yamaguchi
4 joint publications
Koji Yamanoi
4 joint publications
Masaki Mandai
3 joint publications
Tsukasa Baba
2 joint publications
J B Brown
2 joint publications
Hisamitsu Takaya
2 joint publications
Taito Miyamoto
2 joint publications
Kosuke Yoshihara
